The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine - Snoeck, E; Jacqmin, P; Van Peer, A; Danhof, M; Ver Donck, K; Van Belle, H; Woestenborghs, R; Crabbé, R; Van Gool, R; Dupont, A; Heykants, J (Br J Clin Pharmacol, 1996)